EGFR and adenocarcinoma: According to a meta-analysis conducted to characterize the patterns of mutation incidence in NSCLC, the frequency of EGFR mutations was 47.9% in adenocarcinoma (ADC) and 4.6% in squamous cell carcinoma (SCC) in Asian populations.